Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment
Dr. John Fleetham chats with Dr. Paolo Denti, Dr. Elisa Ignatius, Dr. Jason Andrews, and Dr. Neil Schluger about two papers and an editorial published in AJRCCM discussing the use of isoniazid in treating patients with tuberculosis.
Articles discussed in today's episode:
A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
Using Isoniazid More Safely and More Effectively: The Time Is Now [Editorial]
[Note: The episode was updated on February 24, 2022, to fix an audio editing error.]
A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
Using Isoniazid More Safely and More Effectively: The Time Is Now [Editorial]
[Note: The episode was updated on February 24, 2022, to fix an audio editing error.]